Integral Health Asset Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,050,000
| Closed | -$35M | – | 99 |
|
|
2024
Q3 | $35M | Sell |
1,050,000
-50,000
| -5% | -$1.67M | 3.94% | 5 |
|
|
2024
Q2 | $29.7M | Buy |
1,100,000
+125,000
| +13% | +$3.38M | 2.82% | 8 |
|
|
2024
Q1 | $21.1M | Buy |
975,000
+75,000
| +8% | +$1.62M | 1.95% | 14 |
|
|
2023
Q4 | $5.43M | Buy |
900,000
+140,000
| +18% | +$844K | 0.74% | 53 |
|
|
2023
Q3 | $4.23M | Buy |
760,000
+162,000
| +27% | +$901K | 0.59% | 54 |
|
|
2023
Q2 | $4.39M | Buy |
598,000
+16,000
| +3% | +$117K | 0.54% | 56 |
|
|
2023
Q1 | $2.33M | Buy |
582,000
+339,000
| +140% | +$1.36M | 0.47% | 58 |
|
|
2022
Q4 | $792K | Buy |
243,000
+133,000
| +121% | +$434K | 0.17% | 58 |
|
|
2022
Q3 | $409K | Buy |
110,000
+52,665
| +92% | +$196K | 0.08% | 64 |
|
|
2022
Q2 | $177K | Buy |
57,335
+9,735
| +20% | +$30.1K | 0.04% | 65 |
|
|
2022
Q1 | $254K | Buy |
47,600
+17,600
| +59% | +$93.9K | 0.07% | 71 |
|
|
2021
Q4 | $146K | Hold |
30,000
| – | – | 0.04% | 70 |
|
|
2021
Q3 | $266K | Hold |
30,000
| – | – | 0.08% | 70 |
|
|
2021
Q2 | $274K | Hold |
30,000
| – | – | 0.08% | 71 |
|
|
2021
Q1 | $491K | Buy |
+30,000
| New | +$491K | 0.14% | 67 |
|